Matthew Ocko - Net Worth and Insider Trading

Matthew Ocko Net Worth

The estimated net worth of Matthew Ocko is at least $115 Million dollars as of 2024-12-03. Matthew Ocko is the Director of Rocket Lab USA Inc and owns about 4,766,192 shares of Rocket Lab USA Inc (RKLB) stock worth over $115 Million. Details can be seen in Matthew Ocko's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Ocko has not made any transactions after 2024-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Matthew Ocko

To

Matthew Ocko Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Ocko owns 6 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Zymergen Inc (ZY) , and AbCellera Biologics Inc (ABCL) among others .

Click here to see the complete history of Matthew Ocko’s form 4 insider trades.

Insider Ownership Summary of Matthew Ocko

Ticker Comapny Transaction Date Type of Owner
RXRX Recursion Pharmaceuticals Inc 2021-04-15 10 percent owner
ZY Zymergen Inc 2021-04-21 director
ABCL AbCellera Biologics Inc 2020-12-11 10 percent owner
LIMIT LIMIT 2024-11-15 director
LIMIT LIMIT 2021-11-10 10 percent owner
LIMIT LIMIT 2021-11-10 10 percent owner

Matthew Ocko Latest Holdings Summary

Matthew Ocko currently owns a total of 1 stock. Matthew Ocko owns 4,766,192 shares of Rocket Lab USA Inc (RKLB) as of November 15, 2024, with a value of $115 Million.

Latest Holdings of Matthew Ocko

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RKLB Rocket Lab USA Inc 2024-11-15 4,766,192 24.16 115,127,368

Holding Weightings of Matthew Ocko


Matthew Ocko Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Ocko has made a total of 1 transactions in Rocket Lab USA Inc (RKLB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rocket Lab USA Inc is the sale of 5,366,193 shares on November 15, 2024, which brought Matthew Ocko around $97 Million.

Insider Trading History of Matthew Ocko

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Ocko Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Ocko Ownership Network

Ownership Network List of Matthew Ocko

No Data

Ownership Network Relation of Matthew Ocko

Insider Network Chart

Matthew Ocko Owned Company Details

What does Recursion Pharmaceuticals Inc do?

Who are the key executives at Recursion Pharmaceuticals Inc?

Matthew Ocko is the 10 percent owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , Chief Financial Officer Michael Secora , and President and COO Tina Marriott Larson .

Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary

Over the past 18 months, Matthew Ocko made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 489,810 shares made by Blake Borgeson , a net sale of 1,249,278 shares made by Christopher Gibson , and a net sale of 728,124 shares made by Michael Secora .

In summary, during the past 3 months, insiders sold 279,235 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 279,235 shares. During the past 18 months, 2,992,353 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,992,353 shares.

Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Recursion Pharmaceuticals Inc Insider Transactions

No Available Data

Matthew Ocko Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Ocko. You might contact Matthew Ocko via mailing address: 270 University Avenue, Palo Alto Ca 94301.

Discussions on Matthew Ocko

No discussions yet.